Molecular Imaging To Expand To $6.18 Billion By 2026
Molecular Imaging to Expand to $6.18 Billion by 2026
X-rays, computed tomography (CT), and ultrasound diagnostic imaging procedures offer photos of physical structure. Molecular imaging gives physicians a window into the body s function, with an ability to measure it chemically and biologically.
Other imaging technologies are unable to provide information that is attainable with molecular imaging. Biopsies or surgeries could be required to identify disease with other diagnostic tests.
Molecular imaging is a powerful tool for physicians.
It is helpful to achieve the following: - Manage patient care
- Determine disease severity
- Select proper therapy
- Analyze drug response
- Assess and adapt treatment
- Respond to changes in health
- Evaluate disease progression
- Identify disease resurgence
- Manage ongoing care
The demand in molecular systems is driven by: - Technological advancements
- Rising prevalence of disorders
- Large aging population
- Government support
- Hybrid modality treatments
North America leads the worldwide molecular imaging market, while the Asian Pacific is the speediest in terms of expansion due to rising healthcare spending.
RadParts is the world s largest independent distributor of OEM replacement parts. We specialize in low-cost parts for repairing linear accelerator and radiation equipment. Our mission is to provide high-quality, user-friendly, low-cost parts and support for linear accelerators and radiation equipment. Contact RadParts at 877-704-3838 or visit us on the web: https://www.radparts.com.
Written by the digital marketing staff at Creative Programs & Systems: www.cpsmi.com.
- Understanding Linear Accelerators and Their Role in Cancer Treatment
- Israeli Child Receives Pioneering Seated Proton Therapy with Innovative System
- Significant Milestone Reached in Compact Particle Accelerator Technology
- Innovative Radiotherapy Method Potentially Halves Treatment Duration for Head and Neck Cancer
- WSU Veterinary Hospital Installs a New Linear Accelerator to Fight Cancer
- Patients Privately Pay $2,500 for a Full-Body MRI Scan to Detect Cancer
- MIT and Dana-Farber's Breakthrough in Identifying Cancer Origins
- Available Diagnostic Imaging for Smaller Communities & Young Athletes
- New MR, PET Images Analyze Alzheimer’s Biomarkers
- Prostate Cancer Treatment Vastly Improved